Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Clinical trial NCT00039910 · COMPLETED

Trial details

NCT number: NCT00039910
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Hodgkin Disease Thrombocytopenia

Start date: 2000-07-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.